Author

Yunfei Wen

Observed names: Y Wen, yunfei wen

Observed institutions: Nebraska Medical Center, Shanghai Medical College of Fudan University, The University of Texas MD Anderson Cancer Center, Genentech, Fudan University, Athenex (United States), Obstetrics and Gynecology Hospital of Fudan University, Huazhong University of Science and Technology, University of Nebraska Medical Center

OpenAlex ID: A5059434798

Nuclear Association of the Cytoplasmic Tail of MUC1 and β-Catenin

2003 · Yunfei Wen, Thomas C. Caffrey, et al. · Journal of Biological Chemistry · 164

Platelet-Derived Growth Factor Receptor β–Mediated Phosphorylation of MUC1 Enhances Invasiveness in Pancreatic Adenocarcinoma Cells

2007 · Pankaj K. Singh, Yunfei Wen, et al. · Cancer Research · 107

Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

2013 · Tao Liu, Wei Hu, et al. · Clinical Cancer Research · 40

Interactions between MUC1 and p120 Catenin Regulate Dynamic Features of Cell Adhesion, Motility, and Metastasis

2013 · Xiang Liu, Chunhui Yi, et al. · Cancer Research · 33

MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin

2014 · X Liu, T C Caffrey, et al. · Oncogenesis · 31

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

2017 · Yinghong Pan, Gordon Robertson, et al. · Oncotarget · 7

Endothelial p130cas Confers Resistance to Anti-Angiogenesis Therapy

2020 · yunfei wen, Anca Chelariu- Raicu, et al. · SSRN Electronic Journal · 2

Abstract AP21: A NOVEL TARGET FOR OVERCOMING ADAPTIVE RESISTANCE TO ANTI-ANGIOGENIC THERAPY IN OVARIAN CANCER

2019 · Yunfei Wen, Alpa M Nick, et al. · Clinical Cancer Research

Works count: 8

Citation count: 384

H-index: 6

I10-index: 5